Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Wim H. Scheele"'
Autor:
Kenneth J. Koval, Jared Christensen, Alexandre Valentin, Francois Huard, Mohit Bhandari, Thomas R. Lyon, Eduardo Gomez Sanchez, Wim H. Scheele
Publikováno v:
The Journal of Bone & Joint Surgery. 95:2088-2096
Background: Recombinant human bone morphogenetic protein-2 (rhBMP-2) applied on an absorbable collagen sponge improves open tibial fracture-healing as an adjunct to unreamed intramedullary nail fixation. We evaluated rhBMP-2 and a new, injectable cal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a5f097a38b151e5f489cc8e11fbb855
https://doi.org/10.2106/jbjs.l.01545
https://doi.org/10.2106/jbjs.l.01545
Autor:
Nihad Tamimi, Rosalind Walley, Vu Le, Susan Diamond, Fernando Grover-Páez, Meguid El Nahas, Jeremy D. Gale, Timothy P. Rolph, Valerie Clerin, Christelle Perros-Huguet, Wim H. Scheele
Diabetic nephropathy (DN) is the leading cause of ESRD worldwide. Reduced bioavailability or uncoupling of nitric oxide in the kidney, leading to decreased intracellular levels of the nitric oxide pathway effector molecule cyclic guanosine monophosph
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::55b68f0d3441f2ea3505f6aaec52efc9
https://europepmc.org/articles/PMC5084877/
https://europepmc.org/articles/PMC5084877/
Autor:
S. Adami, JM Kaufman, S Paul, Wim H. Scheele, Adolfo Diez-Perez, Gregory A Gaich, Eric S. Orwoll, A D Clancy, Unni Syversen
Publikováno v:
Europe PubMed Central
Teriparatide [rhPTH(1-34)] increases bone mineral density and reduces the risk of vertebral fracture in women. We randomized 437 men with spine or hip bone mineral density more than 2 SD below the young adult male mean to daily injections of placebo,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a6eff985f54d59df63cb857a8352adb
https://doi.org/10.1359/jbmr.2003.18.1.9
https://doi.org/10.1359/jbmr.2003.18.1.9
Publikováno v:
American Journal of Obstetrics and Gynecology. 182:568-574
Objective: We sought to compare the uterine effects of raloxifene with those of continuous-combined hormone replacement therapy. Study Design: This randomized, double-blind 24-month study involved 136 postmenopausal women who received raloxifene 150
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d100cc1a2db8d1bd82bc29e3587790c9
https://doi.org/10.1067/mob.2000.104768
https://doi.org/10.1067/mob.2000.104768
Autor:
STEVEN R. GOLDSTEIN, WIM H. SCHEELE, SRIKANTH K. RAJAGOPALAN, JENNIFER L. WILKIE, BRIAN W. WALSH, ANNA K. PARSONS
Publikováno v:
Obstetrics & Gynecology. 95:95-103
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ad7b15fe4e97bbfe4a1fb7b534eafd2b
https://doi.org/10.1097/00006250-200001000-00019
https://doi.org/10.1097/00006250-200001000-00019
Publikováno v:
Osteoporosis International. 7:52-58
The purpose of this open, prospective, controlled, randomized trial was to study the effect of intermittent, cyclic etidronate on the bone mass of osteoporotic postmenopausal women with or without fractures. Eligible subjects were asymptomatic women
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42cc3a49981555a27648fae0f66f7725
https://doi.org/10.1007/bf01623461
https://doi.org/10.1007/bf01623461
Autor:
Per Aspenberg, René Rizzoli, Art Santora, Wim H. Scheele, John A. Kanis, Michael Wagener, David Marsh, S. Ormarsdottir, D Ethgen, Jean-Yves Reginster, Bruce H. Mitlak, Isabelle Dupin-Roger, Peter Augat, Pierre D. Delmas, Maria-Luisa Brandi, Beate P. Hanson, Eric Abadie, Gerhard Schmidmaier, Reshma Kewalramani, Andrea Laslop, Arkadi Chines, F. Hartl, Jörg Goldhahn, Nansa Burlet
Publikováno v:
Bone, Vol. 43, No 2 (2008) pp. 343-7
Pre-clinical studies indicate that pharmacologic agents can augment fracture union. If these pharmacologic approaches could be translated into clinical benefit and offered to patients with osteoporosis or patients with other risks for impaired fractu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c54578823da25736b1b827ec89382fc0
https://pubmed.ncbi.nlm.nih.gov/18544475
https://pubmed.ncbi.nlm.nih.gov/18544475
Autor:
Anthony B. Hodsman, Paul D. Miller, Ricardo Correa-Rotter, Jean-Jacques Body, Anne Peretz, Wim H. Scheele, Robin K. Dore, David C. Cumming, Gregory A Gaich, Pandurang M. Kulkarni, Alexandra Papaioannou
Publikováno v:
The Journal of clinical endocrinology and metabolism. 87(10)
Teriparatide (rDNA origin) injection [recombinant human PTH (1–34)] stimulates bone formation, increases bone mineral density (BMD), and restores bone architecture and integrity. In contrast, bisphosphonates reduce bone resorption and increase BMD.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15ae548011def1aa019b797eecb46606
https://pubmed.ncbi.nlm.nih.gov/12629137
https://pubmed.ncbi.nlm.nih.gov/12629137
Publikováno v:
The Journal of clinical endocrinology and metabolism. 87(3)
More skeletal benefit has reportedly been achieved using two antiresorptive treatments in combination, presumably because these treatments have different mechanisms of action. Bisphosphonates such as alendronate (ALN) bind to hydroxyapatite and inhib
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05b90838b8b90d27d8e3107938d5ae96
https://pubmed.ncbi.nlm.nih.gov/11889148
https://pubmed.ncbi.nlm.nih.gov/11889148
Autor:
Wim H Scheele, Anna K. Parsons, Brian W. Walsh, Srikanth K Rajagopalan, Jennifer L Wilkie, Steven R. Goldstein
Publikováno v:
Obstetrics and gynecology. 95(1)
To determine the effects of a selective estrogen receptor modulator, raloxifene, on postmenopausal endometrium.Healthy postmenopausal women (n = 415) were randomly assigned to one of the following four groups: 60 or 150 mg/day raloxifene hydrochlorid
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c0529d4c88016e0603928b7efb4289e
https://pubmed.ncbi.nlm.nih.gov/10636510
https://pubmed.ncbi.nlm.nih.gov/10636510